About Acme Formulation Private Limited
Data last updated:
Acme Formulation Private Limited is a private limited company based in Himachal Pradesh, India, a subsidiary of Pagac Ariane Pte Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 June 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24230HP2004PTC027223. Its GSTIN is 02AAECA7994C1ZT (Himachal Pradesh). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹18 Cr and a paid-up capital of ₹10.25 Cr. It is led by directors including Viral Shah (Managing Director) and Vikas Sharma (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Village Chowkiwalatehsil Nalagarh Distt Solan, Himachal Pradesh, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹577 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹71.71 Cr (net margin 12.4%) and EBITDA of ₹123.8 Cr (EBITDA margin 21.5%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 12% over five years.
The company has about 601 employees on its provident fund (EPFO) records. Its group structure includes 4 subsidiaries.
The company is associated with 1 brand: Acme Generics. As per MCA filings, the company has open charges of ₹115.72 Cr and satisfied charges of ₹202.58 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website acmegenerics.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressVillage Chowkiwalatehsil Nalagarh Distt Solan, Himachal Pradesh, India
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Acme Formulation Private Limited
Acme Formulation operates one associated brand: Acme Generics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Solid and liquid formulations are manufactured as a CDMO focus. | acmegenerics.in |
Competitors & Alternatives of Acme Formulation Private Limited
Brands and companies operating in the same space as Acme Formulation Private Limited include Abzena, Syngene, Grand River Aseptic Manufacturing and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Abzena | Provider of antibody discovery, cell line development, and bio analytics services | Cambridge, United Kingdom | 2001 |
 Syngene | Provider of contract research and manufacturing services for both small molecules and biologics | Bengaluru, India | 1993 |
 Grand River Aseptic Manufacturing | Sterile parenteral CDMO services for development and manufacturing are offered. | Grand Rapids, United States | 2010 |
 Patheon | Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry | Durham, United States | 1974 |
 Panacea Biotec | Developer of biosimilars, vaccines and natural products | Ambala, India | 1984 |
 Piramal Group | Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate | Mumbai, India | 1984 |
 Maravai Life Sciences | Provides enabling tools and services in the life sciences research and bio-production industries | San Diego, United States | 2014 |
 LakePharma | Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering | Belmont, United States | 2009 |
 Insud Pharma | Finished formulations, APIs, and monoclonal antibodies are developed and manufactured. | Madrid, Spain | 1977 |
Business Activity of Acme Formulation Private Limited
The main business activity of Acme Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Acme Formulation Private Limited
Acme Formulation Private Limited is audited by S. R. Batliboi & Co. LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S. R. Batliboi & Co. LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Acme Formulation Private Limited
Acme Formulation has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Viral Shah Also directs: Ambriel Life Sciences LLP, Acme Generics Private Limited, Tekno Touch Private Limited and 3 more | Managing Director | 24 Jan 2007 | 19 Years 8 Months | Current |
| Aswin Vikram Also directs: Nuvama Wealth Management Limited, Pagac Advisors India Private Limited, Alternicq Limited and 4 more | Director | 04 Oct 2021 | 5 Years 0 Months | Current |
| Vikas Sharma Also directs: Acme Generics Private Limited, Ace Testing Solutions Private Limited, Ace Invest Private Limited and 1 more | Whole-Time Director | 29 Jul 2020 | 6 Years 2 Months | Current |
| Nikhil Kumar Srivastava | Director | 04 Oct 2021 | 5 Years 0 Months | Current |
Financials of Acme Formulation Private Limited FY 2024 filings available
Acme Formulation Private Limited reported revenue of ₹577 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Acme Formulation Private Limited
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Acme Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹123.8 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹71.71 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Acme Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 12.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Acme Formulation are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Acme Formulation Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Acme Formulation Private Limited
Acme Formulation has 4 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Acme Generics Private Limited | U24100PB2021PTC056566 | Locked |
| Ace Testing Solutions Private Limited | U74140HP2009PTC031248 | Locked |
| Ace Invest Private Limited | U74900CH2013PTC034318 | Locked |
| Immacule Lifesciences Private Limited | U74900HP2010PTC031676 | Locked |
Showing major subsidiaries. Total: 4.
Charges & Borrowings of Acme Formulation Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Aug 2021 | State Bank of India | ₹50.72 Cr | Open |
| 17 Jan 2020 | Hdfc Bank Limited | ₹30.5 Cr | Open |
| 17 Jan 2020 | Hdfc Bank Limited | ₹8.5 Cr | Open |
| 17 Jan 2020 | Hdfc Bank Limited | ₹26 Cr | Open |
| 23 Nov 2016 | Hdfc Bank Limited | ₹25.5 Cr | Satisfied |
Total charge records: 18 View all charges
Employees and EPFO Compliance at Acme Formulation Private Limited
Acme Formulation Private Limited has a workforce of 601 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Acme Formulation Private Limited
Acme Formulation has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAECA7994C1ZT | Himachal Pradesh | Active | 01 Jul 2017 |
| 04AAECA7994C2ZO | Chandigarh | Active | 21 Jul 2017 |
| 03AAECA7994C1ZR | Punjab | Active | 25 Oct 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Acme Formulation Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Acme Formulation Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Acme Formulation Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Acme Formulation Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Acme Formulation Private Limited
Frequently Asked Questions about Acme Formulation Private Limited
Acme Formulation is an active private limited company based in Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 June 2004 (22+ years old) and is registered under CIN U24230HP2004PTC027223.
Acme Formulation reported revenue of ₹577 Cr for FY 2025 (down 2% YoY).
Acme Formulation has 4 current directors:
- Viral Shah - Managing Director
- Vikas Sharma - Whole-Time Director
- Aswin Vikram - Director
- Nikhil Kumar Srivastava - Director
Acme Formulation reported a net profit of ₹71.71 Cr (net margin 12.4%) and EBITDA of ₹123.8 Cr (EBITDA margin 21.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Acme Formulation is 2% over three years and 12% over five years. In the latest year (FY 2025) revenue fell 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Acme Formulation is 02AAECA7994C1ZT, registered in Himachal Pradesh. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 04AAECA7994C2ZO (Chandigarh), 03AAECA7994C1ZR (Punjab).
The CIN (Corporate Identification Number) of Acme Formulation is U24230HP2004PTC027223. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acme Formulation was incorporated on 21 June 2004, making it 22+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Acme Formulation can be reached through the website acmegenerics.in. Its registered office is in Himachal Pradesh, India.